This compound, known as tert-butyl ((1S,5R,6S)-3-azabicyclo[3.3.0]octan-6-yl)carbamate or its diastereomeric mixture, is a chiral bicyclic amine derivative. It features a fused cyclopentane-pyrrolidine (cyclopenta[c]pyrrolidine) core structure, which is a privileged scaffold in medicinal chemistry. The tert-butyloxycarbonyl (Boc) group serves as a standard protecting group for the amine functionality. Its primary and well-documented application is as a key chiral intermediate in the synthesis of pharmaceutical agents. Most notably, it is a critical building block in the industrial-scale production of Ticagrelor, a widely used antiplatelet drug (P2Y12 receptor antagonist) for the prevention of thrombotic events in patients with acute coronary syndrome. The specific stereochemistry of the bicyclic core is essential for the biological activity of the final drug molecule. The compound is typically handled as a high-purity solid and is commercially supplied for research and development as well as for cGMP manufacturing processes. Its synthesis and application underscore its importance as a specialized, high-value intermediate in modern asymmetric synthesis for the pharmaceutical industry.